Completed PHASE2 INTERVENTIONAL NCT00288743

Adherence, Efficacy and Safety of an Insulin Protocol in the Critically Ill: A Prospective Observational Study

Sponsor: University Hospital, Ghent

Interventions to implement an insulin protocol with target blood glucose levels between 81-110 mg/dL.

Updated 5 times since 2017 Last updated: Dec 19, 2007 Started: Sep 30, 2002 Completion: Dec 31, 2002

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00288743, this PHASE2 trial focuses on Critically Ill Patients and remains completed. Sponsored by University Hospital, Ghent, it has been updated 5 times since 2002, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Sep 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Ghent

Data source: University Hospital, Ghent

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ghent, Belgium